Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome.

Trial Profile

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Mar 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clobazam (Primary)
  • Indications Lennox-Gastaut syndrome
  • Focus Therapeutic Use
  • Sponsors Lundbeck Inc
  • Most Recent Events

    • 28 Sep 2016 Results of post-hoc analysis from OV-1004 and OV-1012 studies (n=200) published in the Neurology.
    • 28 Sep 2016 According to Lundbeck A/S media release, Barry Gidal, PharmD, University of Wisconsin School of Pharmacy & Dept. of Neurology is the lead investigator of the post-hoc analyses
    • 21 Apr 2016 Results of a post hoc analysis presented at the 68th Annual Meeting of the American Academy of Neurology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top